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        Introduction 
  Epithelial-mesenchymal transition is the process by which epi-
thelial cells undergo phenotypic and morphological reorgani-
zation. Epithelial-mesenchymal transition is essential during 
embryogenesis for the formation of many tissues, including the 
formation of the mesoderm, the migration of neural crest cells, 
and the development of the heart valves and septa (  Hay, 2005  ). 
Endothelial-to-mesenchymal transition (EMT) is a specifi  c form 
of epithelial-mesenchymal transition that is initiated at embry-
onic day (E)  –  9.5 in the atrioventricular (AV) canal and E10.5 in 
the outfl  ow tract (OFT) cardiac cushions, the two sites of EMT in 
the developing heart ( Camenisch et al., 2002a ). This process gen-
erates cells that contribute to the connective tissue of the valves 
and septa of the adult heart (  Eisenberg and Markwald, 1995  ). 
  Recent studies have demonstrated a critical role of the 
Notch signaling pathway during cardiac EMT, and disruption of 
this pathway has been implicated in the pathogenesis of various 
cardiovascular diseases ( Iso et al., 2003 ;  Niessen and Karsan, 2007 ). 
In the mouse, targeted deletion of   Notch1   or its key nuclear 
partner   CSL   ( CBF1/Suppressor of Hairless/Lag-1 )  results  in 
cardiac cushion EMT defects (  Oka et al., 1995  ;   Timmerman 
et al., 2004  ). Further, targeted deletion of the downstream Notch/
CSL effector   Hey2   or  double-defi  ciency of   Hey1   and   Hey2   or 
  Hey1   and   HeyL   results in various congenital heart anomalies in-
cluding cardiac cushion defects (  Donovan et al., 2002  ;   Fischer 
et al., 2004, 2007  ). In humans, mutations at the   Notch1   locus 
are associated with bicuspid aortic valve disease as well as mi-
tral valve anomalies and tetralogy of Fallot (  Garg et al., 2005  ). 
Further, patients with mutations of the Notch ligand Jagged1 
develop Alagille syndrome, a polymalformative disorder which 
includes cardiac cushion defects (  Li et al., 1997  ;   Oda et al., 1997  ; 
  Eldadah et al., 2001  ). 
 TGF-     –  related pathways have also been shown to be 
essential for proper heart development through their role in 
regulating EMT (  Azhar et al., 2003  ). Of particular interest, 
  BMP2  and  TGF-   2   are expressed by the AV canal cushion myo-
cardium (  Dickson et al., 1993  ;   Zhang and Bradley, 1996  ). BMP2-
defi  cient mice die before cardiac cushion development (  Zhang 
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initiation of cardiac cushion EMT (  Murray and Gridley, 2006  ). 
In the mouse, Slug is expressed in the cardiac cushions at E13.5, 
and mice defi  cient for   Slug   are viable but are growth retarded and 
display defects in pigmentation and hematopoiesis (  Jiang et al., 
1998  ;   Inoue et al., 2002  ). To date, there is no direct evidence 
demonstrating the requirement for any Snail family member dur-
ing mammalian heart development. 
  In this paper, we demonstrate that   Slug   is  fi  rst expressed 
by a subset of endothelial cells as well as mesenchymal cells of 
the AV canal at E9.5, at the initiation of EMT. In keeping with a 
requirement for Slug during the initiation of cardiac EMT, the 
AV canal cushions show markedly reduced cellularization at 
E9.5, which normalizes by E10.5. Concordant with the in vivo 
fi  ndings, AV canal explant assays demonstrate that EMT in 
  Slug -defi  cient embryos is impaired at E9.5 but not E10.5, as 
EMT in   Slug -defi  cient embryos is rescued by an increase in 
  Snail   expression by E10.5. Accordingly, abolishing both   Slug  
and   Snail   expression results in EMT defects at E10.5. In con-
trast to a previous study, we show that Notch signaling, through 
CSL, directly regulates the   Slug   promoter, resulting in the up-
regulation of   Slug  , but not   Snail  , in endothelial cells (  Timmerman 
et al., 2004  ). We further show that   Slug   directly binds and re-
presses the   vascular endothelial cadherin   ( VE-cadherin )  pro-
moter. Slug also promotes increased migration toward PDGF. 
In contrast, TGF-    2 and BMP2 induce   Snail   expression but 
minimal   Slug   expression. However, Notch synergistically in-
duces   Snail   in concert with TGF-    2. Our data demonstrate that 
Notch-induced expression of   Slug   plays an important role in the 
initiation of EMT in the heart but that increased Snail compen-
sates for the lack of Slug in   Slug  -targeted embryos as cardiac 
cushion morphogenesis progresses. 
  Results 
  Activation of the Notch pathway induces 
  Slug   but not   Snail   in endothelial cells 
  It has previously been suggested that EMT initiated by Notch 
may proceed through the induction of Snail; however, the de-
generate primers used in that study amplify both Snail and Slug 
(  Timmerman et al., 2004  ). To clarify which Snail family mem-
bers are regulated by Notch signaling, we activated Notch in 
endothelial cells by ectopically expressing the Notch ligands 
Jagged1 or Dll4 or the constitutively active form of Notch1 
or Notch4 (Notch1ICD and Notch4ICD, respectively), all of 
which are expressed in the cardiac cushion (  Loomes et al., 
1999  ;   Noseda et al., 2004  ). Activated Notch up-regulated   Slug , 
but not   Snail  , in all endothelial cells tested, as demonstrated 
by RT-PCR ( Fig. 1 A ), quantitative RT-PCR (qRT-PCR;  Fig. 1 B ), 
and immunoblotting (  Fig. 1, C and D  ; and see   Fig. 6 B  ). 
[ID]FIG1[/ID]  As a 
positive control, we confi  rmed that the known Notch targets   Hey1 , 
  Hey2  , and   HeyL   were induced by NotchICD (  Fig. 1, A and B  ). 
Additional experiments with NotchICD deletion constructs 
revealed that the Ankyrin repeats of Notch are required for 
induction of Slug (Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200710067/DC1). These fi  ndings indicate 
that Notch activation induces   Slug   but not   Snail   expression  in 
endothelial cells. 
and Bradley, 1996  ); however, defi  ciency of the BMP2 receptor Alk2 
results in AV canal EMT defects (  Wang et al., 2005  ).   TGF-   2   –
 defi  cient mouse embryos do not display obvious cardiac cush-
ion EMT defects, although later remodeling of the AV canal 
cushion is impaired (  Dickson et al., 1993  ;   Sanford et al., 1997  ; 
  Bartram et al., 2001  ;   Molin et al., 2002, 2003  ). However, using 
an ex vivo AV canal explant assay, TGF-  2 – blocking antibodies 
or blocking antibodies for its coreceptor   T   RIII   inhibit  AV 
canal EMT, suggesting redundancy of this pathway in vivo (  Brown 
et al., 1999  ;   Camenisch et al., 2002a  ). These data and others 
have established a clear role of TGF-    – related  pathways  during 
mammalian cardiac cushion development. 
  The Snail family members   Snail   (also known as   Snai1 )  and 
  Slug   (also known as   Snai2  ) encode zinc fi   nger – containing  tran-
scriptional repressors that trigger EMT during embryonic devel-
opment and tumor progression, in part by regulating expression 
of junctional proteins, most notably   E-cadherin   ( Nieto,  2002 ). 
In the mouse,   Snail   has been shown to be expressed in the cardiac 
cushions from E9.5 onwards (  Timmerman et al., 2004  ). Mice de-
fi  cient for   Snail   die at E7.5, before cardiac development, and 
display defects in mesoderm formation (  Carver et al., 2001  ). 
Conditional deletion of   Snail   after E8 results in lethality by E9.5, 
partially because of severe cardiovascular defects, but before the 
  Figure 1.       Expression of   Slug  , but not   Snail  , is induced by Notch activation.   
(A) Analysis of mRNA expression by semi  –  qRT-PCR in human mam-
mary epithelial cells (HMEC) and human umbilical vein epithelial cells 
(HUVEC) expressing constitutively active Notch1 (Notch1ICD) or Notch4 
(Notch4ICD). (B) Analysis of mRNA expression by qRT-PCR in HMEC ex-
pressing Notch1ICD. Results are normalized to the vector control (  n   = 3). 
*, P   <   0.05. Error bars show SEM. (C) Immunoblots for Slug and Snail in 
HMEC, HUVEC, and human aortic endothelial cells (HAEC) transduced 
with Notch1ICD, Notch4ICD, or the empty vector. (D) HMEC expressing 
Jagged1 or Dll4 were cocultured with parental HMEC and immunoblotting 
for Slug was performed.     317 NOTCH INDUCES EMT VIA SLUG   • Niessen et al. 
and   Slug  
   /     AV canal explants had signifi  cantly reduced migra-
tion and invasion compared with   Slug  
+/      or wild-type controls 
at E9.5 (  Fig. 3, A and B  ). 
[ID]FIG3 [/ID]  Of the few   Slug  
   /     cells that did 
migrate, many had a rounded morphology, and were not able 
to differentiate into spindled mesenchymal cells. Analysis 
of     -galactosidase activity in   Slug  
+/      AV explants revealed 
  Slug   expression in the migrating cells as well as the proximal 
    Slug   is expressed in a subset of endothelial 
cells and the mesenchymal cells of the AV 
canal, OFT, and valves of the embryonic 
mouse and human heart 
  It has been reported that   Slug   mRNA is not expressed at E9.5 in 
the cardiac cushion (  Timmerman et al., 2004  ), which suggests 
that it is dispensable for cardiac EMT. Because Notch activation 
has been shown to be critical for EMT during cardiac cushion 
development (  Noseda et al., 2004  ;   Timmerman et al., 2004  ), we 
were interested in defi  ning the expression of   Slug   during the 
period of cellularization of the mammalian cardiac cushions. 
We thus examined   Slug-lacZ   mice, which have the   lacZ   gene in-
serted into the   Slug   locus with concomitant deletion of the zinc 
fi  nger DNA binding motifs. Expression of   lacZ   in this model 
has been shown to faithfully match expression of   Slug   mRNA 
in all tissues analyzed, as determined by in situ hybridization 
(  Jiang et al., 1998  ).     -galactosidase staining of E9.5  –  11.5 embryos 
showed that   Slug  -expressing cells were abundant in the heart 
(  Fig. 2 A  ) with expression within a subset of endothelial cells as 
well as the mesenchymal cells of the AV canal and OFT at E9.5, 
with increasing expression over E10.5 and 11.5 ( Fig. 2 B ). 
[ID]FIG2[/ID]  Detailed 
analysis of   Slug   expression around E9.5 revealed that   Slug   ex-
pression is induced in the AV canal at the 25  –  28-somite stage 
at the initiation of EMT (Fig. S2, available at http://www.jcb
.org/cgi/content/full/jcb.200710067/DC1). Immunofl  uorescent 
staining for Slug protein at E11.5 confi  rmed expression in the 
cardiac cushion mesenchyme and a subset of endothelial cells 
that costained for CD31 (  Fig. 2 C  , arrowheads). 
  It has been suggested that EMT continues to take place 
to allow valvular remodeling later in development as well as in 
the adult (  Armstrong and Bischoff, 2004  ). To confi  rm a role 
for Snail family members in the human heart, we examined 
expression of   Snail   and   Slug   in embryonic human hearts at 
various developmental stages (days 52  –  78 of gestation) with 
similar results at various stages.   Fig. 2 D   shows that   Snail  
and   Slug   are both expressed in the tricuspid and mitral valves, 
the AV septum, and the interatrial septum in a 65-d human 
heart. This staining pattern is similar to   Slug   expression in later 
stages of mouse heart development (  Oram et al., 2003  ). Higher 
magnification images revealed that the mesenchymal cells 
of the valves, as well as endothelial cells at the root of the 
valves, express   Snail   and   Slug   (  Fig. 2 D  ), suggesting a role for 
Snail family members in human cardiac cushion development 
and remodeling. 
    Slug   is necessary for EMT in the 
cardiac cushions 
  To determine whether targeted disruption of the   Slug   gene has a 
functional effect on cardiac cushion development, the AV canal 
of E9.5 embryos were placed on collagen gels to monitor EMT 
ex vivo, as previously described (  Camenisch et al., 2002a  ;   Chang 
et al., 2004  ). Occasional endothelial cell outgrowths occur 
proximal to 100   μ  m of the AV canal explant. Therefore, only the 
morphologically distinct mesenchymal cells distal to 100   μ  m 
from the AV canal were quantitated to determine the degree 
of EMT. Homozygous   Slug-LacZ   mutants behave as   Slug  
   /    
(  Slug -defi  cient) animals (  Jiang et al., 1998  ;   Inoue et al., 2002  ), 
  Figure 2.         Slug   expression during cardiac cushion development.   (A)     -galacto-
sidase staining (representing   Slug   expression) of whole-mounted hearts 
from   Slug-lacZ 
+/        embryos from E9.5 to 11.5. Arrows point to the AV canal 
or OFT at E11.5. Bars, 250   μ  m. (B) Sections through the AV canal and OFT 
of     -galactosidase  –  stained   Slug-lacZ 
+/        hearts from E9.5 to 11.5. Bars, 
100   μ  m. (C) Immunoﬂ  uorescence staining for Slug (red) and CD31 (green) 
in E11.5 embryonic mouse hearts. Arrowheads point to cells coexpressing 
Slug and CD31. Bars, 25   μ  m. (D) In situ hybridization for   Snail   and   Slug   
in a 65-d human embryonic heart. Arrows point to the mitral and tricuspid 
valves, arrowheads indicate the interatrial septum, and the asterisk marks 
the AV septum. A higher magniﬁ  cation image of the heart valve is shown 
in the right panel of each analysis. Bars, 1 mm.     JCB • VOLUME 182 • NUMBER 2 • 2008  318
and mesenchyme in   Slug  
   /     embryos (  Fig. 3 F  ). Although the 
increase in BrdU incorporation was small, a greater pool of endo-
cardial cells able to undergo EMT combined with increased 
mesenchymal proliferation may be suffi  cient to normalize cush-
ion cellularity by E10.5. In contrast, quantitation of active cas-
pase-3 to enumerate the numbers of cells undergoing apoptosis 
did not reveal much cell death (  <   1%) in either wild-type or 
  Slug  
   /     AV canals, with no difference between the two groups 
(unpublished data). 
  To determine whether   Slug   is  suffi  cient to promote a mo-
tile phenotype in endothelial cells, endothelial cells were trans-
duced with vector or Slug, and an in vitro wound healing (scratch) 
assay was performed. The scratch assay revealed increased 
migration of Slug-expressing endothelial cells as early as 4 h 
and up to 24 h after wounding of the endothelial monolayer, re-
sulting in Slug-expressing cells migrating almost twice as far 
after 24 h (  Fig. 3 G  ). PDGF has been shown to be expressed in 
the cardiac cushions during EMT (  Van Den Akker et al., 2005  ). 
Using a modifi  ed Boyden chamber assay with 20 ng/ml PDGF-BB 
present in the lower chamber, we found that Slug-expressing 
endothelial cells showed signifi  cantly increased directed migra-
tion toward PDGF-BB (  Fig. 3 H  ). Thus, Slug expression in the 
endothelium appears to be suffi  cient for endothelial motility and 
directed migration. 
cardiac endothelial cells (  Fig. 3 C  ). Interestingly, the majority of 
   -galactosidase staining was seen in rounded cells, which is 
consistent with morphology of cells that are intermediate be-
tween endothelial and mesenchymal phenotype, as previously 
described (  Camenisch et al., 2002b  ). 
 To  confi  rm that cushion cellularization was impaired in 
Slug-defi  cient embryos in vivo, E9.5 hearts were serially sec-
tioned (between 7 and 20 sections for each heart) and the num-
ber of cushion cells was quantitated in every section. At E9.5, 
  Slug  
   /     embryos had signifi  cantly fewer mesenchymal cells in 
the cardiac cushions compared with wild-type controls (  Fig. 3, 
D and E  ). However, by E10.5 there was no difference in cellu-
larity of the cardiac cushions, and a defect in AV canal EMT 
ex vivo was not evident (Fig. S2). These fi  ndings implicate 
  Slug   in the early activation and migration of endothelial cells 
during cushion EMT with potential compensation by other 
factors later in cardiac cushion development. To investigate 
the reason for the normalization of cardiac cushion cellular-
ization by E10.5, the degree of cardiac cushion apoptosis and 
proliferation was evaluated. AV canal endocardial and mesen-
chymal cell proliferation was measured by BrdU incorporation 
and no difference in S-phase entry was noted at E9.5 (unpub-
lished data). However, analysis at E10.25 revealed that there 
is an increase in BrdU incorporation in both the endocardium 
  Figure 3.         Slug   
    /      embryos display defects 
in AV canal EMT at E9.5.   (A) Phase contrast 
(left) and DAPI (right) images of AV canal ex-
plants from wild-type and   Slug   
    /      embryos. 
Bars, 250   μ  m. (B) Quantitative analysis of 
EMT in AV canal explants from E9.5 wild-type 
(wt),   Slug   
+/     , and   Slug   
    /      embryos after 48 h 
in culture. Results represent the distance of 
a positive pixel (DAPI-stained nucleus) to the 
closest point of the AV canal normalized to 
the area of the AV canal tissue. *, P   <   0.05. 
(C)   Slug   expression in the AV canal explant 
assay as visualized by     -galactosidase stain-
ing of wild-type and   Slug-lacZ 
+/        AV explants. 
The rounded morphology of most of the LacZ 
+   
cells is shown on the right. The black square 
indicates the region of higher magniﬁ  cation 
shown to the right. Bars, 50   μ  m. (D) Represen-
tative sections of wild-type and   Slug   
    /      hearts 
counterstained with Nuclear Fast Red used for 
analysis in E. Dotted blue lines highlight the su-
perior and inferior AV cushions. Bars, 50   μ  m. 
(E) Quantitation of the cellularity of the supe-
rior and inferior cushions in E9.5 wild-type (wt; 
  n   = 3) and   Slug 
    /        (  n   = 3) embryos. Error bars 
show SEM. (F) BrdU analysis on the percent-
age of proliferating cells in wild-type (  n   = 4) 
and   Slug 
    /        (  n   = 6) AV canal cardiac cushions 
(total), the AV canal endocardium (Endo), and 
AV canal mesenchymal cells (Mesen; 10  –  15 
sections per embryo). Error bars show SEM. 
(G) Vector- or Slug-transduced HMEC were 
subjected to an endothelial wounding assay. 
Bars represent the distance migrated after 24 h 
(  n   = 4). *, P   <   0.05. Error bars show SD. 
(H) Vector- or Slug-transduced HMEC were evalu-
ated in a modiﬁ   ed Boyden chamber assay 
with 20 ng/ml PDGF-BB present in the lower 
chamber. Bars represent the total number of 
cells migrated after 4 h (  n   = 6). *, P   <   0.05. 
Error bars show SD.     319 NOTCH INDUCES EMT VIA SLUG   • Niessen et al. 
  HeyL   (  Fig. 5 D  ). However, enforced expression of the Notch 
targets Hey1 or Hey2, which have been implicated in cardiac 
EMT, did not up-regulate Slug or repress VE-cadherin (Fig. S3). 
Together, these fi  ndings indicate that Notch, via CSL, directly 
up-regulates   Slug   expression and that   Slug   is the Notch target 
responsible for repressing VE-cadherin expression. 
 Analysis of the human and mouse  Slug  promoters (  2,000 
to +100 relative to the TSS) identifi  ed six putative CSL binding 
    Slug   represses endothelial phenotype 
  Given our fi  ndings demonstrating the requirement of   Slug   in car-
diac EMT, we sought to examine the role that   Slug   plays in modu-
lating the endothelial phenotype. Enforced expression of Slug 
repressed expression of key endothelial genes such as  VE-cadherin , 
  CD31 ,  and   Tie2   as determined by qRT-PCR, immunoblotting, and 
immunofl  uorescence (  Fig. 4, A and B  ; and Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200710067/DC1). 
[ID]FIG4[/ID]  How-
ever, in contrast to activated Notch, Slug did not induce the 
mesenchymal markers smooth muscle     -actin and h1-calponin 
( Fig.  4  B ).  These  fi  ndings suggest that Slug expression promotes 
the initial phases of EMT associated with the loss of endothelial 
phenotype but is not suffi  cient to complete the transition into a 
mesenchymal cell that is mediated by Notch activation. 
  VE-cadherin   is a key endothelial adherens junction pro-
tein that is required for maintenance of endothelial homeostasis 
and that must be down-regulated before endothelial remodeling 
(  Crosby et al., 2005  ). We thus determined whether Slug was 
capable of directly repressing   VE-cadherin .  Promoter  analysis 
of human   VE-cadherin   identifi  ed two putative Slug binding 
E2-box (CACCTG) motifs 5     to the transcriptional start site (TSS), 
located at     306 to     311 and     379 to    384  ( Prandini  et  al., 
2005  ). As demonstrated by electrophoretic mobility shift assays 
(EMSA), Slug was capable of binding both E2-box motifs, but 
was unable to bind a CAGCTG E-box element located at    97 
to     102 in the human   VE-cadherin   promoter (  Fig. 4 C  ). Of the 
three cis elements tested in the human VE-cadherin promoter, 
only the     379 to     384 E2-box and the     97 to    102  E-box 
motifs are conserved in the mouse   VE-cadherin   promoter.  Con-
sistent with the EMSA result, mutation of the E2-box, but not 
the E-box motif, signifi  cantly reduced the ability of Slug to re-
press the mouse   VE-cadherin   promoter as measured by lucifer-
ase assays ( Fig. 4 D ). Thus,  VE-cadherin  transcription is directly 
repressed by Slug binding to the E2-box promoter elements in 
endothelial cells. 
  Notch acts through CSL to induce   Slug   
and repress the endothelial phenotype 
  We next determined whether Notch induces   Slug   through the ca-
nonical CSL-dependent pathway or the less well-defi  ned CSL-
independent route ( Ramain et al., 2001 ). Dll4-mediated induction 
of   Slug   mRNA and protein was dramatically reduced when   CSL  
was knocked down using either of two lentiviral-delivered short 
hairpin RNA (shRNA) constructs, which target distinct regions of 
  CSL   ( Fig.  5,  A – C ). 
[ID]FIG5[/ID]  As expected, induction of the Notch target 
  HeyL   was also abolished by   CSL   knockdown (  Fig. 5 B  ). In addi-
tion, the ability of Notch activation to down-regulate the endo-
thelial markers VE-cadherin and CD31 ( Fig. 5 C ) was abrogated 
when   CSL   was knocked down. We also targeted   Slug   using two 
distinct lentiviral-delivered shRNAs and found that the ability of 
Dll4-activated Notch to down-regulate VE-cadherin and CD31 
was also reversed by Slug knockdown ( Fig. 5 C  and Fig. S3), thus 
demonstrating the requirement of CSL-mediated induction of 
  Slug   for Notch-mediated EMT. Furthermore, activation of CSL 
using a constitutively active CSL mutant (CSL-VP16;     MacKenzie 
et al., 2004  ) demonstrated that CSL activation alone was suffi  -
cient to up-regulate   Slug   expression as well as the Notch target 
  Figure 4.       Slug represses the endothelial phenotype and directly regulates 
the   VE-cadherin   promoter.   (A) Analysis of endothelial marker expression by 
qRT-PCR in Slug-transduced HMEC (  n   = 3). *, P   <   0.05. (B) Immunoblots for 
endothelial and mesenchymal markers in empty vector  –  , NotchICD-, and 
Slug-expressing HMEC. (C) EMSA using in vitro  –  translated luciferase (Luc) 
or Slug-FLAG protein and  
32  P-labeled double-stranded oligonucleotides for 
an E-box cis element (    97) or two putative   Slug   E2-box motifs (    306 
and     379) in the human   VE-cadherin   promoter. Supershift assays with 
anti  –  FLAG-M2 or IgG control antibodies and competition assays with 50  ×   
wild-type (wt) or mutant probes are also shown. (D) Promoter activity in 
endothelial cells cotransfected with vector or Slug plasmids and wild-type, 
E2-box mutant, or E-box mutant mouse   VE-cadherin   promoter-luciferase 
constructs (  n   = 4; each experiment performed in triplicate). *, P   <   0.05. 
Error bars show SEM.     JCB • VOLUME 182 • NUMBER 2 • 2008  320
  Slug   promoter (  Fig. 5 E  ). In contrast, PCR of the same ChIP 
DNA did not enrich the   ZNF3   promoter, which lacks a putative 
CSL binding site. EMSA of nuclear lysates harvested from 
FLAG-CSL  –  expressing endothelial cells confi  rmed that CSL 
is capable of binding both consensus elements present in the 
human   Slug   promoter (  Fig. 5 F  ). Collectively, these data demon-
strate that  Slug  is a direct target of Notch through a CSL-dependent 
pathway and that Slug induction is required for Notch-mediated 
repression of the endothelial phenotype. 
  Notch and TGF-     act synergistically to 
induce   Snail   
  Components of the TGF-     pathway have been shown to be re-
quired for EMT and for the regulation of Snail family genes dur-
ing heart development (  Romano and Runyan, 2000  ;   Camenisch 
et al., 2002a  ;   Wang et al., 2005  ). Additionally, the Notch and 
TGF-     pathways have been shown to coregulate target gene 
expression in various cell types (  Blokzijl et al., 2003  ;   Zavadil 
et al., 2004  ). To investigate the relationship between the Notch 
and TGF-     pathways and Snail family member expression, endo-
thelial cells cocultured with vector- or Dll4-transduced cells 
were treated with 2.5 ng/ml TGF-    2 or 20 or 50 ng/ml BMP2. 
TGF-   2 stimulation induced maximal induction of  Snail  mRNA 
and protein expression after 2 h of treatment in vector-transduced 
cells, followed by rapid down-regulation (  Fig. 6, A and B  ). 
[ID]FIG6 [/ID]  
Although Dll4 stimulation alone did not induce   Snail ,  combined 
activation of the Notch and TGF-     pathways resulted in a syn-
ergistic increase of   Snail   mRNA levels and maintenance of ex-
pression for at least 8 h after stimulation with TGF-   2  ( Fig.  6 A ). 
Protein expression of Snail peaked slightly later (4 h) and was sus-
tained at a much higher level in the context of Dll4 and TGF-   2 
costimulation compared with TGF-    2 stimulation alone (  Fig. 6 B  ). 
In contrast, there was minimal induction of   Slug   by  TGF-  2, 
whereas Notch activation alone dramatically up-regulated   Slug  
(  Fig. 6, B and C  ). Costimulation by Dll4 and TGF-    2 did not 
increase the level of   Slug   induction over that seen with Dll4 
alone (  Fig. 6, B and C  ). 
  To investigate the role of Notch activation in TGF-   2 – 
mediated induction of   Snail  , we used the    -secretase  inhibitor 
DAPT to block ligand-activated Notch signaling. TGF-   2  treat-
ment dramatically up-regulated the expression of   Snail ,  but  the 
addition of DAPT did not affect the ability of TGF-   2  to  induce 
  Snail  , which is consistent with Notch-independent induction 
(  Fig. 6 C  ). In the context of combined Notch and TGF-   2  acti-
vation, the synergistic up-regulation of   Snail   expression was 
reduced by DAPT to the level seen by TGF-   2  stimulation 
alone (  Fig. 6 C  ). TGF-    2 had no effect on   Slug   levels, and the 
addition of DAPT abrogated   Slug   induction by Dll4, suggest-
ing complete dependence on Notch activation for   Slug   up-
regulation (  Fig. 6 C  ). Similar results were observed with TGF-   1 
treatment (Fig. S4, available at http://www.jcb.org/cgi/content/
full/jcb.200710067/DC1). As expected, stimulation of endo-
thelial cells with TGF-    2 induced expression of   Smad7 ,  a  TGF-    
target gene, to similar levels in control and Notch-activated cells 
(  Fig. 6 C  ). Addition of DAPT appeared to block the ability of 
TGF-    2 to induce   Smad7  , but the results were variable and did 
not reach statistical signifi  cance for TGF-   2  or  TGF-  1  ( Fig.  6  C  
sites ((C/T)(A/G)TG(A/G/T)GA(A/G/T)) in the human and two 
putative CSL binding sites in the mouse. Of the six putative 
binding sites in the human   Slug   promoter, two were further in-
vestigated based on conservation of the   CSL   binding sites in the 
mouse   Slug   promoter.  The  fi  rst binding site (TATGGGAA) is 
located at     846 to     853, whereas the second binding site 
(TGTGGGAA) is located at     1,679 to     1,686 upstream of the 
TSS. Using chromatin immunoprecipitation (ChIP) followed by 
PCR with primers fl  anking the CSL elements, we found that 
CSL was capable of binding both CSL consensus motifs in the 
  Figure 5.       Notch signaling regulates   Slug   expression through a CSL-
dependent pathway.   (A) qRT-PCR analysis demonstrating efﬁ  cient knockdown 
of   CSL   in HMEC with two different shRNAs targeting   CSL   (shCSL) com-
pared with a random control sequence (shRan). (B) qRT-PCR of   Slug   and 
  HeyL   in vector- or Dll4-activated HMEC transduced with shCSL constructs 
(  n   = 3). *, P   <   0.05 vector shRandom versus HA-D114 shRandom; **, P   <   
0.05 HA-D114 shRandom versus HA-D114 shCSL-A or shCSL-B. (C) Immuno-
blotting for Slug, VE-cadherin, and CD31 in vector- or Dll4-activated 
HMEC transduced with shCSL or shSlug constructs. (D) qRT-PCR of vector- 
or CSL-VP16  –  expressing HMEC for   Slug   and   HeyL   (  n   = 3). *, P   <   0.05. 
(E) PCR after ChIP with anti  –  FLAG-M2 antibody on HMEC-expressing vec-
tor (vec) or FLAG-CSL (CSL) to demonstrate CSL binding to the human   Slug   
promoter. The negative (-ve) control represents PCR of the   ZNF3   promoter 
after ChIP using FLAG-M2. (F) EMSA using nuclear lysates collected from 
vector- or FLAG-CSL  –  expressing HMEC and  
32  P-labeled double-stranded 
oligonucleotides spanning each of the two CSL binding sites in the human 
  Slug   promoter. Supershift assays with anti  –  FLAG-M2 or IgG control anti-
bodies, and competition assays with 50  ×   wild-type (wt) or mutant probes 
are also shown. Error bars show SEM.     321 NOTCH INDUCES EMT VIA SLUG   • Niessen et al. 
TGF-     pathways.  These  fi  ndings clearly confi  rm that   Slug   is  a 
direct target of Notch and that   Snail   is not but that   Snail   is syn-
ergistically induced when Notch activation is superimposed on 
TGF-     stimulation. 
    Snail   and   Slug   cooperatively induce 
cardiac EMT 
  Given that the cardiac EMT defect seen in   Slug  
   /     mice at E9.5 
was reduced by E10.5 (  Fig. 3, A and B  ; and Fig. S2), we sought 
to determine whether   Snail   was compensating for the absence of 
  Slug   in vivo. qRT-PCR analysis of wild-type and   Slug  
   /     hearts 
was conducted for   Snail   and   Slug .   Slug   expression increased 
from E9.5 to 11.5 in the wild-type heart and its expression was 
abolished in the   Slug 
   /       hearts. In contrast,   Snail   expression did 
not increase from E9.5 to 11.5 in the wild-type hearts. However, 
in the   Slug 
   /       hearts Snail was up-regulated 3.6-fold by E11.5 
( Fig.  7 A ). 
[ID]FIG7[/ID]  In situ hybridization at E10.5 and 11.5 revealed   Snail  
expression in the AV canal and OFT in both wild-type and   Slug  
   /    
hearts, with increased expression in the  Slug  
   /    embryos ( Fig. 7 B ), 
suggesting that the region of   Snail   expression is not expanded 
but, rather, that the cells normally expressing   Snail   do so at a 
higher level in the   Slug 
   /       hearts. 
  We next determined whether the TGF-     pathway,  poten-
tially through   Snail  , could compensate for   Slug   defi  ciency at 
E9.5. Treatment of E9.5 AV canal explants with 5 ng/ml TGF-   2 
completely rescued the EMT defect seen in E9.5   Slug  
   /     em-
bryos (  Fig. 7 C  ). Given the increase in   Snail   expression  noted 
at E10.5 and 11.5 in   Slug  
   /     hearts (  Fig. 7, A and B  ), the ability 
of   Snail   to compensate for the absence of   Slug   after E9.5 was 
directly assessed using a lentiviral-delivered shRNA to knock 
down   Snail   expression in   Slug  
   /     E10.5 AV canal explants. 
Knockdown of   Snail   in wild-type or heterozygote   Slug   AV  ex-
plants did not result in a decrease in the number or distance of 
migrating cells at E10.5 (  Fig. 7 D  ). In contrast, knockdown of 
  Snail   in   Slug  
   /     AV explants resulted in a signifi  cant reduction 
in the number of migrating/invading cells (  Fig. 7 D  ). The degree 
of EMT is reduced in E10.5 AV canals compared with E9.5 AV 
canals, which is consistent with previous data (  Dor et al., 2001  ; 
  Chang et al., 2004  ). These data support the redundancy of   Slug  
and   Snail   during the later stages of EMT in the cardiac cushions 
and suggest that parallel activation by the Notch and TGF-    –
  BMP pathways is required to maintain the appropriate level of 
expression of Snail family members in order for cushion devel-
opment to proceed. 
  Discussion 
  The Notch signaling pathway has been found to be a key regu-
lator of cardiac cushion EMT and has been implicated in the 
pathogenesis of various cardiovascular diseases (  Niessen and 
Karsan, 2007  ). TGF-      –  related pathways have also been shown 
to be essential for proper heart development through their role 
in regulating EMT (  Azhar et al., 2003  ). Thus, there are clear 
requirements for both the Notch and TGF-    – related  pathways 
during mammalian cardiac cushion development. However, there 
is limited detail of how these pathways function and interact with 
each other during cardiac development. Our fi  ndings suggest 
and Fig. S4), suggesting a minimal role for Notch activation in 
TGF-    – induced   Smad7   induction.   Hey1   expression was in-
duced by Notch signaling and TGF-    2 and was dependent on 
active Notch signaling (  Fig. 6 C  ). Similar to what has been 
described for BMP4/6,   Hey1   was also synergistically induced to 
very high levels by TGF-    2 and Dll4 (  Fig. 6 C  ;   Dahlqvist et al., 
2003  ;   Itoh et al., 2004  ). 
 Similar  to  TGF-   2, when endothelial cells were stimulated 
with BMP2 there was dramatic up-regulation of   Snail   expression, 
minimal up-regulation of   Slug  , and synergistic activation of   Hey1  
in Notch activated cells (  Fig. 6 D  ). However, unlike TGF-   2, 
combined activation of the Notch pathway and BMP2 stimula-
tion did not synergistically up-regulate   Snail   expression (  Fig. 6 D  ). 
This suggests that a Smad3-dependent process is involved in 
the synergistic activation of   Snail   expression by the Notch and 
  Figure 6.       Induction of   Snail   by TGF-    2 is synergistically enhanced in Dll4-
activated endothelial cells.   (A) qRT-PCR for   Snail   mRNA in vector- or Dll4-
activated HMEC treated with 2.5 ng/ml TGF-    2 for the indicated times 
(  n   = 3). *, P   <   0.05. (B) Immunoblots for Snail and   Slug   in vector- or Dll4-
activated HMEC treated with 2.5 ng/ml TGF-    2. (C) qRT-PCR for   Snail  ,   
Slug  ,   Hey1  , and   Smad7   mRNA in vector- or Dll4-activated HMEC treated 
with 10   μ  M DMSO or DAPT for 16 h followed by treatment with 2.5 ng/ml 
TGF-    2 for 3 h (  n   = 3). *, P   <   0.05. (D) qRT-PCR for   Snail  ,   Slug  ,   Hey1  , 
and   Smad7   mRNA in vector- or Dll4-activated HMEC treated with 20 or 
50 ng/ml BMP2 (  n   = 3). Error bars show SEM.     JCB • VOLUME 182 • NUMBER 2 • 2008  322
  Using an AV canal explant model, we demonstrate that 
  Slug -defi  cient hearts have a specifi  c defect in cardiac cushion 
EMT at E9.5 but not at E10.5. In   Slug -defi  cient hearts at E10.5, 
cardiac EMT is compensated for by a relative increase in   Snail  
expression. Accordingly, inducing   Snail   expression by treatment 
with TGF-    2 at E9.5 rescues the EMT defect in   Slug -defi  cient 
mice. Conversely, abolishing both   Slug   and   Snail   expression  re-
sults in EMT defects at E10.5. Consistent with a requirement for 
both   Snail   and   Slug   during cardiac EMT, both members are ex-
pressed during mouse and human heart development with similar 
localization in a subset of endothelial cells and the mesenchymal 
cells of the AV canal and OFT. It is of interest that deletion of  Slug  
results in up-regulation of   Snail .  This  fi  nding suggests that   Slug  
may act to repress   Snail  , either by directly targeting the   Snail  
promoter or through the repression of elements of the TGF-    –  
related or Notch pathways. Consistent with the latter hypothesis, 
we have seen that both   Hey2   and   Smad7   are up-regulated in   Slug -
defi  cient hearts at E11.5 (unpublished data). Additionally, it has 
been demonstrated that Slug does not affect  Snail -promoter activ-
ity ( Peiro et al., 2006 ), which we have verifi  ed (unpublished data). 
Our fi  ndings are concordant with a recent study showing that 
Snail heterozygosity increases the penetrance of palate defects in 
Slug-defi  cient mice, suggesting that Snail also compensates for 
Slug defi  ciency during palate development (  Murray et al., 2007  ). 
In addition, the fi  nding that there is increased   Slug   expression  in 
the developing palate in   Snail -defi  cient embryos (  Murray et al., 
2007  ) suggests reciprocal regulation of gene expression between 
  Slug   and   Snail . 
  The interaction between the Notch and TGF-     pathways 
likely occurs at multiple levels and may be context-dependent. 
Targeting of   CSL   results in reduced   TGF-   2    and its receptor   
TBRII   in the mouse heart (  Timmerman et al., 2004  ). In contrast, 
cooperation between the Notch and TGF-    – BMP  pathways  during 
cardiac EMT, through the coordinate regulation of a group of 
genes such as the Snail family of transcription factors. In con-
trast to a previous study, we demonstrate that the transcriptional 
repressor   Slug  , but not   Snail  , is a direct target of the Notch 
pathway (  Timmerman et al., 2004  ). Conversely, activation of 
the TGF-     pathway dramatically up-regulates the expression of 
  Snail   but not   Slug ,  and   Slug   is not required for TGF-    – mediated 
EMT. Importantly we reveal synergistic up-regulation of   Snail  
expression by the Notch and TGF-     pathways, despite the fact 
that   Snail   is not a direct target of Notch. This synergistic acti-
vation of TGF-    – induced   Snail   by Notch is consistent with the 
decrease in   Snail   expression seen in   CSL -defi  cient embryos 
(  Timmerman et al., 2004  ). 
 Interestingly,  endothelial-specifi  c gene targeting of the 
BMP receptor   Alk2   results in cardiac cushion defects that are 
associated with a decrease in the expression of   Snail ,  but  not 
  Hey2   or   Slug  , in the AV canal (  Wang et al., 2005  ). In contrast, 
Notch-mediated EMT is cell autonomous and TGF-     indepen-
dent (  Noseda et al., 2004  ). Collectively, these fi  ndings support 
the data presented herein that   Slug   is a direct target of the Notch 
pathway and that   Snail   is a target of TGF-    – related  pathways. 
  We show for the fi  rst time that   Slug   is expressed in a sub-
set of cardiac endothelial cells and the mesenchyme of the 
AV canal and OFT from the onset of EMT at E9.5 and is essen-
tial for initiating cardiac cushion cellularization. We further 
demonstrate that Slug binds and represses the   VE-cadherin   pro-
moter, inducing a motile phenotype. Taken with the defect in 
AV canal EMT at E9.5, the ability of Slug to bind and repress the 
  VE-cadherin   promoter and induce migration suggests that the 
activation phase of EMT in the endocardium is impaired by loss 
of   Slug . 
  Figure 7.       Increased   Snail   expression compensates 
for   Slug   deﬁ  ciency.   (A) qRT-PCR analysis for   Snail   and 
  Slug   of whole hearts isolated from E9.5, 10.5, and 
11.5 wild-type (wt) and   Slug   
    /     embryos (  n   = 3). 
*, P   <   0.05. Error bars show SEM. (B) In situ hybrid-
ization for   Snail   in E10.5 and 11.5 wild-type (wt) and 
  Slug   
    /      hearts (  n   = 3; ﬁ  ve embryos in each replicate). 
Bars, 250   μ  m. (C) Quantitation of EMT in AV canal ex-
plants from E9.5 wild-type (wt) or   Slug   
+/      and   Slug   
    /      
embryos treated with 5 ng/ml TGF-    2 or vehicle (UT). 
(D) Quantitation of EMT in AV canal explants from 
E10.5 wild-type (wt) or   Slug   
+/      and   Slug   
    /      embryos 
transduced with shRandom or shSnail constructs.     323 NOTCH INDUCES EMT VIA SLUG   • Niessen et al. 
on 5% Tris-borate EDTA gels and exposed to a phosphorimager plate for 
12  –  16 h. For CSL EMSA assays, nuclear lysates were collected from FLAG-
CSL  –  overexpressing HMEC cells. Binding reaction and detection were the 
same as used for   Slug  -FLAG EMSA assays. 
  ChIP 
  HMEC were transduced with pLNCX or pLNC-FLAG-  CSL  , and ChIP assay 
was performed as previously described (  Noseda et al., 2006  ). ChIP DNA 
was ampliﬁ  ed for the   ZNF3   promoter or the two CSL binding sites in the 
human   Slug   promoter using primers listed in Table S1. 
  Mice and AV explant assay analysis 
    Slug  -lacZ mice were provided by T. Gridley (Jackson Laboratories, Bar 
Harbor, ME).   Slug-lacZ   
+/      mice were crossed to C57BL/6J mice for em-
bryo collection. Embryos were assayed for     -galactosidase activity in situ 
using published protocols (  Nagy et al., 2003  ). AV canal explants were 
performed as previously described (  Camenisch et al., 2002a  ). Explants 
were cultured for 48 h and analyzed for the number and distance of 
migrating cells. 
  RNA interference 
  shRNAs targeting human   CSL  ,   Snail  , and   Slug   were cloned into the HpaI  –
  XhoI sites of the pLentilox3.7 vector (gift from L. Van Parijs, Massachusetts 
Institute of Technology, Cambridge, MA; Table S1). Constructs were se-
quence veriﬁ  ed and validated for efﬁ  cient knockdown. 
  Collection of human tissues 
  Human embryonic hearts were collected, after institutionally approved proto-
cols and informed consent, at the Children  ’  s and Women  ’  s Health Sciences 
Centre (Vancouver, Canada). Tissue was ﬁ  xed in 4% PFA overnight, embed-
ded in OCT, and cryosectioned. 
  In situ hybridization 
  In situ hybridization was performed as previously described (  Wilkinson, 
1992  ). Mouse   Snail   probe (    55 to +454) was cloned into pBluescript. 
Human   Snail   and human   Slug   probes were comprised of the entire ORF 
cloned into pCDNA3. 
  BrdU analysis 
    Slug-lacZ   
+/      male and female mice were crossed and pregnant females 
were injected with 1,500 mg/ml BrdU (Sigma-Aldrich) 2 h before killing. 
Embryos were collected, parafﬁ  n embedded, and sectioned (6   μ  m) onto 
Histobond slides (Marienfeld Laboratory Glassware). Slides were boiled 
for 30 min in 0.1M citrate buffer, rinsed in water, and then denatured in 
2N HCl for 45 min at 37  °  C. Slides were then rinsed in PBS, and BrdU 
staining was performed using mouse anti-BrdU (BU33; Sigma-Aldrich) and 
goat anti  –  mouse Alexa 488 (Invitrogen). 
  Online supplemental material 
  Fig. S1 shows that the ankyrin repeats of NotchICD are required for induc-
tion of Slug expression. Fig. S2 shows the Slug-lacZ expression in the 18 
to 29 somite stage heart and that the AV canal EMT defect observed in 
Slug-deﬁ   cient embryos at E9.5 is no longer present at E10.5. Fig. S3 
shows that Slug represses endothelial cell phenotype in HMEC and 
HUVEC, that the knockdown of Slug expression in Notch-activated cells re-
stores VE-cadherin and CD31 expression, and that the ectopic expression 
of Hey1 or Hey2 does not induce Slug expression or repress VE-cadherin 
expression. Fig. S4 shows that the induction of Snail by TGF-    1 is synergis-
tically enhanced in Notch-activated endothelial cells. Table S1 is a list 
of primers used in this study. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200710067/DC1. 
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the Notch-ligand   Jagged1   has been shown to be induced by 
TGF-    at the onset of EMT in epithelial cells ( Zavadil et al., 2004 ). 
Despite our evidence showing cooperation of the TGF-     and 
Notch pathways in cardiac cushion development, several stud-
ies have suggested that constitutively active NotchICD inhibits 
TGF-     signaling through the sequestration of Smad3 or the co-
activator p300 (  Masuda et al., 2005  ;   Sun et al., 2005  ). However, 
overexpression of NotchICD may have resulted in artifactual 
sequestering of TGF-     signaling components. Alternatively, the 
outcome of Notch  –  TGF-     cross talk may be dependent on the 
context. Indeed, in mouse embryonic endothelial cells, BMP sig-
naling synergizes with NotchICD through a ternary interaction 
between Smad5, NotchICD, and p/CAF (  Itoh et al., 2004  ). 
  Combining the fi  ndings in this paper with published data, 
one can propose a model where endothelial Notch activation 
induces   Slug   and release of TGF-     and BMPs from the cushion 
myocardium activates the cardiac endothelium to up-regulate 
  Snail  , which is enhanced in Notch-activated cells. Based on the 
  Slug -defi  cient hearts and RNAi studies in the AV explants, a 
minimal total dose of   Snail / Slug   is required in order for EMT to 
be initiated at E9.5, with a diminishing requirement at E10.5 as 
cushion development proceeds. 
  Materials and methods 
  Reagents 
  The mouse monoclonal antibody against the FLAG epitope (M2), mouse 
anti  –  h1-calponin, and mouse anti-tubulin were purchased from Sigma-
Aldrich. Goat anti  –  VE-cadherin (C-19), goat anti-CD31 (C-20), and goat 
anti-Slug (G-18) were obtained from Santa Cruz Biotechnology Inc. Rabbit 
anti  –  Snail antibody was obtained from Abcam. Mouse anti  –  VE-cadherin 
(TEA1/31) was obtained from Beckman Coulter. Rabbit anti  –        –  smooth 
muscle actin antibody was obtained from Thermo Fisher Scientiﬁ  c. 
  Cell culture and gene transfer 
  The HMEC-1 human microvascular endothelial cell line, HUVEC, and hu-
man aortic endothelial cells were obtained and cultured as previously de-
scribed (  Noseda et al., 2004  ). Endothelial cells were transduced using the 
retroviral vectors pLNCX, pLNC-  Slug  -FLAG, pLNC-FLAG-  CSL  , MIY, MIY-  Slug  -
FLAG, MIY-  Notch4IC  -HA, MIY-  Notch1IC  , and MIY-  CSL-VP16   as previously 
described (  Karsan et al., 1996  ). pcDNA3-  Slug  -FLAG cDNA was a gift from 
E.R. Fearon (The University of Michigan Heath Systems, Ann Arbor, MI). 
  RNA collection and RT-PCR 
  RNA was isolated and cDNA was made as previously described (  Noseda 
et al., 2004 ). PCR was performed on a PCR cycler (PTC-200 [Bio-Rad Labora-
tories] or 7900HT [Applied Biosystems]) with primers listed in Table S1 (avail-
able at http://www.jcb.org/cgi/content/full/jcb.200710067/DC1). 
  Luciferase reporter assay 
  8   ×   10 
4   HMEC was plated 24 h before transfection in 24-well plates. 
HMEC were transfected using SuperFect (QIAGEN) reagent, with 0.3125   μ  g 
of total plasmid DNA as per the manufacturer  ’  s recommendations. Each 
well was transfected with 0.3   μ  g of the VE-cadherin promoter plasmid or 
mutant VE-cadherin promoter constructs, 5 ng pcDNA3 or pcDNA3-  Slug  -
FLAG, and 7.5 ng pRL-CMV (Promega). Luminescence was measured 
on a Lumat LB 9507 (EG  &  G Berthold) 24 h after transfection using dual 
luciferase reporter assays according to the manufacturer  ’  s recommenda-
tions (Promega). 
  EMSA 
  For Slug EMSA assays, in vitro  –  translated (TNT; Promega) Slug-FLAG or 
control luciferase protein was preincubated with FLAG-M2 antibody over-
night at 4  °  C in 12 mM Hepes, pH 7.9, 4 mM Tris, pH 7.9, 133 mM KCl, 
10% Glycerol, and 2   μ  g PolydI-dC binding buffer. 50-fold excess non-
radioactive duplex oligos were preincubated for 15 min on ice, and then 
150,000-cpm  
32  P-labeled double-stranded oligo nucleotides were added 
and incubated for 30 min at room temperature. Binding reactions were run JCB • VOLUME 182 • NUMBER 2 • 2008  324
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